EXOPHARM
Exopharm is an Australian regenerative medicine biopharmaceutical company that is seeking to develop and commercialise exosomes as therapeutic agents – initially a product called Plexaris™ and later as a product called Exomeres™.
EXOPHARM
Industry:
Biopharma Biotechnology
Founded:
2013-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.exopharm.com
Total Employee:
11+
Status:
Active
Contact:
+61 (0)3 9111 0026
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.exopharm.com Semrush global rank: 3.89 M Semrush visits lastest month: 3.28 K
- Host name: syn03ee.syd5.hostyourservices.net
- IP address: 43.250.142.68
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Exopharm"
Exopharm - Crunchbase Company Profile & Funding
Organization. Exopharm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Exopharm is an Australian regenerative …See details»
News - Exopharm
Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production Melbourne, Australia and Ajdovščina, …See details»
Exopharm - Org Chart, Teams, Culture & Jobs - The Org
View Exopharm's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Exopharm - businessabc.net
Feb 25, 2025 Exopharm is a medical technology company dedicated to transforming the lives of people with hard-to-manage chronic conditions. We develop world-class remote care solutions …See details»
EXOPHARM - AnnualReports.com
EXOPHARM ANNUAL REPORT 2020 1 CONTENTS Exopharm Snapshot 2-3 Letter from Board Chair & CEO 4-5 Director’s Report 6-7 Review of Operations 8-16 Remuneration Report …See details»
Exopharm - Funding, Financials, Valuation & Investors - Crunchbase
Dec 18, 2018 Exopharm is a clinical human therapeutics using exosomes as regenerative medicine products. New. Resources. Advanced Search. ... Experience the new Crunchbase, …See details»
Exopharm Company Profile - Office Locations, Competitors ... - Craft
May 10, 2024 Exopharm is a biopharmaceutical company that specializes in the development of genetic medicines. It offers engineered extracellular vesicles (EEVs) for neurology, cardiology, …See details»
Exopharm - Overview, News & Similar companies | ZoomInfo.com
Who is Exopharm. Exopharm Limited (ASX:EX1) is a clinical-stage biopharmaceutical company at the forefront of transformative medicines using exosomes, or extracellu lar vesicles (EVs), and …See details»
EXOPHARM: Shareholders Board Members Managers and …
EXOPHARM: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Australian S.E.: EX1 | Australian S.E.See details»
Exopharm Ltd | VentureRadar
Exopharm Limited (ASX:EX1) is a clinical-stage Australian biotechnology company developing extracellular vesicle (EV)/exosome-based therapeutics. Exopharm is developing engineered …See details»
Exopharm - Contacts, Employees, Board Members, Advisors
Exopharm is a clinical human therapeutics using exosomes as regenerative medicine products.See details»
Exopharm Limited - AnnualReports.com
Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular …See details»
Exopharm Limited (EX1.AX) Company Profile & Facts - Yahoo …
See the company profile for Exopharm Limited (EX1.AX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Sartorius BIA Separations and Exopharm sign joint research …
Nov 23, 2022 This work with Exopharm has the potential to be a game-changer in the emerging exosome field.” Dr Ian Dixon, founder and CEO of Exopharm, commented “BIA’s CIM columns …See details»
Exopharm Limited Appendix 4E Preliminary final report 1.
Exopharm’s exclusive proprietary LOAD and EVPS technologies enable the modification of exosomes to carry medical cargo to specific cell types, making Exopharm one of just a handful …See details»
Target Market Determination - Exopharm
Mar 28, 2024 Target Market Determination Made by: Exopharm Limited (to be renamed Tryptamine Therapeutics Limited) (ACN 163 765 991) (Company) Effective Date: 28 March …See details»
Exopharm - ONdrugDelivery
Exopharm is a clinical-stage biopharmaceutical company that uses extracellular vesicles (EVs) to deliver a new class of transformative medicines. Its technologies provide advanced …See details»
Exopharm a LEAP ahead of competitors in emerging exosome
May 26, 2022 “Exopharm’s technologies, our growth strategy, and our team make EX1 an exciting company for investors looking for exposure to the future of modern medicine …See details»
Exopharm Ltd (ASX:EX1) Share Price - Market Index
Exopharm Limited (EX1) is a leader in advanced manufacturing technologies for exosome-based medicines. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) …See details»
Exopharm Gains US Patent Enabling Commercial Production of …
Dec 22, 2021 US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology.; LEAP™ enables large-scale, clinical grade …See details»